BioCentury
ARTICLE | Clinical News

Exocell preclinical data

June 17, 1996 7:00 AM UTC

Exocell presented results in diabetic mice showing that A717 prevents damage in diabetic retinopathy, in which glycated albumin has been shown to play a role. Accelerated glycation of albumin, driven by high blood sugar, damages the retina as well as the kidney. Data were presented at the American Diabetes Association meeting in San Francisco. ...